南模生物
(688265)
| 流通市值：35.87亿 | | | 总市值：35.87亿 |
| 流通股本：7796.35万 | | | 总股本：7796.35万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 123,995,787.94 | 183,237,020.5 | 81,602,566.53 | 200,731,445.41 |
| 交易性金融资产 | 863,193,541.65 | 823,187,204.09 | 899,011,615.49 | 810,361,574.62 |
| 应收票据及应收账款 | 132,021,540.44 | 127,541,453.91 | 134,686,583.41 | 112,118,916.27 |
| 其中：应收票据 | 129,550 | 37,550 | - | - |
| 应收账款 | 131,891,990.44 | 127,503,903.91 | 134,686,583.41 | 112,118,916.27 |
| 预付款项 | 3,587,678.28 | 3,098,220.59 | 3,579,265.48 | 2,037,806.85 |
| 其他应收款合计 | 1,595,280.47 | 1,613,474.41 | 1,905,533.91 | 1,879,489.12 |
| 存货 | 17,779,992.92 | 15,419,869.61 | 15,810,036.2 | 12,669,784.69 |
| 其他流动资产 | 8,294,722.18 | 7,504,336.48 | 8,931,914.72 | 8,485,732.08 |
| 流动资产合计 | 1,150,468,543.88 | 1,161,601,579.59 | 1,145,527,515.74 | 1,148,284,749.04 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 80,106,335.29 | 59,006,335.29 | 59,006,335.29 | 57,006,335.29 |
| 固定资产 | 244,526,365.17 | 250,427,389.75 | 257,401,676.66 | 262,397,156.11 |
| 在建工程 | 81,134,436.88 | 68,996,225.89 | 68,787,135.13 | 68,099,821.01 |
| 使用权资产 | 31,591,002.42 | 52,852,215.09 | 58,130,875.26 | 66,964,977.12 |
| 无形资产 | 236,735,574 | 238,624,786.63 | 240,089,745.94 | 241,310,349.7 |
| 长期待摊费用 | 47,518,858.81 | 50,769,145.35 | 54,489,842.63 | 58,759,923.58 |
| 递延所得税资产 | 26,363,109.04 | 25,952,705.2 | 26,745,881.23 | 25,765,160.66 |
| 其他非流动资产 | 770,313.71 | 692,170.7 | 936,602.04 | 768,061.56 |
| 非流动资产合计 | 748,745,995.32 | 747,320,973.9 | 765,588,094.18 | 781,071,785.03 |
| 资产总计 | 1,899,214,539.2 | 1,908,922,553.49 | 1,911,115,609.92 | 1,929,356,534.07 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 29,376,708.73 | 24,994,166.32 | 32,018,908.73 | 26,538,313.76 |
| 应付账款 | 29,376,708.73 | 24,994,166.32 | 32,018,908.73 | 26,538,313.76 |
| 预收款项 | 510,270.82 | 364,200.93 | - | - |
| 合同负债 | 86,774,432.83 | 81,462,215.91 | 88,581,875.28 | 91,390,498.11 |
| 应付职工薪酬 | 17,558,117.04 | 21,696,867.77 | 15,795,589.31 | 28,165,870.5 |
| 应交税费 | 1,671,854.57 | 1,121,710.11 | 856,249.61 | 1,815,651.94 |
| 其他应付款合计 | 1,952,224.27 | 1,766,896.88 | 2,412,119.98 | 2,597,081.16 |
| 一年内到期的非流动负债 | 16,201,439.31 | 23,930,424 | 24,301,684.95 | 24,669,879.36 |
| 流动负债合计 | 154,045,047.57 | 155,336,481.92 | 163,966,427.86 | 175,177,294.83 |
| 非流动负债: | | | | |
| 租赁负债 | 25,008,665.93 | 42,610,592.72 | 46,661,034.06 | 52,746,162.2 |
| 递延收益 | 16,996,244.78 | 18,098,817.01 | 16,177,031.62 | 16,918,483.95 |
| 递延所得税负债 | 1,074,586.07 | 1,111,729.38 | 1,171,766.78 | 1,514,072.59 |
| 非流动负债合计 | 43,079,496.78 | 61,821,139.11 | 64,009,832.46 | 71,178,718.74 |
| 负债合计 | 197,124,544.35 | 217,157,621.03 | 227,976,260.32 | 246,356,013.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 77,963,513 | 77,963,513 | 77,963,513 | 77,963,513 |
| 资本公积 | 1,557,791,491.01 | 1,555,971,728.51 | 1,566,465,273.99 | 1,565,311,776.96 |
| 减:库存股 | 62,086,095.9 | 62,086,095.9 | 62,086,095.9 | 62,086,095.9 |
| 其他综合收益 | 236,200.23 | 328,430.45 | 348,079.29 | 391,345.04 |
| 盈余公积 | 20,162,524.6 | 20,162,524.6 | 20,162,524.6 | 20,162,524.6 |
| 未分配利润 | 108,022,361.91 | 99,424,831.8 | 80,286,054.62 | 81,257,456.8 |
| 归属于母公司股东权益合计 | 1,702,089,994.85 | 1,691,764,932.46 | 1,683,139,349.6 | 1,683,000,520.5 |
| 股东权益合计 | 1,702,089,994.85 | 1,691,764,932.46 | 1,683,139,349.6 | 1,683,000,520.5 |
| 负债和股东权益合计 | 1,899,214,539.2 | 1,908,922,553.49 | 1,911,115,609.92 | 1,929,356,534.07 |
| 公告日期 | 2025-10-30 | 2025-08-29 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |